EGFL7 Antikörper
-
- Target Alle EGFL7 Antikörper anzeigen
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser EGFL7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Spezifität
- Reacts with human 30 kDa EGFL7 protein
- Aufreinigung
- Purified (protein A)
- Immunogen
- His-tagged EGFL-7 protein
- Klon
- 2H2
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product EGFL7 Primärantikörper
-
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 1-273) antibody
EGFL7 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 24-273) antibodyEGFL7 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2H6 unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 30-80) antibodyEGFL7 Reaktivität: Human, Maus, Ratte ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 24-273) antibodyEGFL7 Reaktivität: Human ELISA Wirt: Maus Monoclonal 3G1 unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 73-198) antibodyEGFL7 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 24-273) antibodyEGFL7 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 1-273) antibodyEGFL7 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 24-100) antibodyEGFL7 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (Internal Region) antibodyVerified EGFL7 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IF 1:100 - 1:500 WB1:200 - 1:1000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water.
- Konzentration
- 1 mg/mL
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powderstable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
- Andere Bezeichnung
- Epidermal Growth Factor-Like Protein 7 (EGF-Like Protein 7) (EGFL7 Produkte)
- Synonyme
- egfl7 antikoerper, MGC53105 antikoerper, EGFL7 antikoerper, zgc:136669 antikoerper, zgc:152804 antikoerper, zneu1 antikoerper, xegfl7 antikoerper, MGC147423 antikoerper, VE-statin antikoerper, Zneu1 antikoerper, NEU1 antikoerper, RP11-251M1.2 antikoerper, VE-STATIN antikoerper, ZNEU1 antikoerper, EGF like domain multiple 7 S homeolog antikoerper, EGF like domain multiple 7 antikoerper, EGF-like-domain, multiple 7 antikoerper, EGF-like domain 7 antikoerper, egfl7.S antikoerper, EGFL7 antikoerper, egfl7 antikoerper, Egfl7 antikoerper
- Hintergrund
- EGFL7 is aberrantly expressed in various cancers. This endothelial protien that regulates vascular tubulogenesis is a marker of metastasis related to poor vital pronostic.
- Gen-ID
- 51162
- UniProt
- Q9UHF1
-
